Nurix Therapeutics Inc (NRIX)
$20.27 -$0.60 (-2.92%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.51B -
Day's Range
$19.90 - $20.84 -
Volume
891,598 -
52 Week Low / High
$7.65 - $29.56 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
NRIX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 8
- Strong Buy
- 6
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $26.75
- Target Price
Company News
-
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL — Jan 16th, 2024
Nurix Therapeutics, Inc. Fast track designation follows positive Phase 1 data presented at the American Society of Hematology that supports strategy to broadly develop NX-5948 in CLL and other non-Hodgkin lymphoma indications SAN FRANCISCO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therape...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$